JUL 25, 2026 · JOURNAL ARTICLE
Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial.
American Heart Journal
This is a vanguard phase report describing trial design, recruitment experiences, and baseline characteristics of 200 randomized participants in an ongoing RCT; no efficacy or safety outcomes are reported.
Reported
Participants screened2514
Participants randomized200
Number of recruiting centers17